From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences
H19
IGF2-P4
H19 + IGF2-P4
Low expression
3/29
5/29
0/29
High expression
26/29
24/29
29/29